Derek Yung
Analyst · Daniel Grosslight from Citi
Thanks, Scott, and good afternoon, everyone. We delivered a strong first quarter, driving higher-than-expected growth in our Medicare and individual family and planned enrollment. First quarter enrollment outperformance was achieved while at the same time, reducing acquisition costs per approved member for Medicare and IFP major medical products. First quarter Medicare revenue of $121 million grew 26% compared to a year ago driven primarily by a 45% increase in approved Medicare members, including a 65% increase in approved Medicare Advantage members. The positive impact of strong growth in our Medicare enrollments was partially offset by lower lifetime values and residual revenue compared to Q1 a year ago. Residual or tail revenue in the Medicare segment was close to 0, in line with our expectations and compared to approximately $9 million a year ago. Our Medicare Advantage LTVs declined 4% compared to Q1 of 2020. This was favorable to our expectations helped by increased contribution from new to MA members and favorable carrier mix. Acquisition costs per approved Medicare Advantage member, which includes marketing and customer care and enrollment costs, declined 12% compared to the first quarter a year ago. The ratio of Medicare Advantage to LTV to total acquisition cost was 1.5, a 9% increase compared to Q1 2020. On an as-adjusted basis, by subtracting carrier advertising dollars from our total acquisition costs, our LTV to COA ratio was 1.7. The ratio of LTV to marketing COA was 2.7, and it was 3.2 on an adjusted basis, excluding carrier advertising dollars. Medicare noncommission revenue grew 5%, roughly in line with our expectations of flat noncommission revenues this year compared to 2020. During the first quarter of 2021, we revised the calculation of segment profit and adjusted EBITDA to exclude amortization of capitalized software development costs. This was done to enhance comparability of our financial metrics with peer public companies. Total amortization of capitalized software was $2.8 million in the first quarter of 2021, with $2.5 million allocated to the Medicare segment and $0.3 million to the IFP and small business segments. In the first quarter of 2020, total amortization of capitalized software was $1.5 million with $1.2 million allocated to the Medicare segment and $0.3 million to the IFP and small business segments. On that basis, the Medicare segment generated a profit of $24.5 million compared to $23.1 million in the first quarter of 2020. Our estimated number of commissions generating Medicare members was approximately 873,000 at the end of the first quarter or an increase of 20% with estimated Medicare Advantage members increasing 33% compared to a year ago. While we continue to manage to policy level profitability as measured by estimated policy LTV to acquisition cost ratio, member level profitability will be an increasingly important consideration going forward. As we build stronger relationships with our members, we will emphasize member retention throughout their experience with Medicare Advantage, which might involve multiple policies across various carriers. Our recapture rates have improved from 11% in 2019 to 14% in 2020 or rather than a 20% year-over-year increase. As we transact a larger share of our enrollments online and grow the number of members on our customer center platform, we expect the cost of recapture to trend down, providing for increasingly attractive member level economics. As Scott described, first quarter estimated trailing 12-month churn from Medicare Advantage plans declined to 42% from 43% a year ago. This estimate is a preliminary view based on our cash collections to date, data from our carrier partners and historical observations. We also report our ending membership number on an estimated basis. Historically, our membership estimates have been on average within 1% of the actual numbers. However, in Q1 of 2020, when we experienced an increase in MA member churn, we overestimated our first quarter ending membership number by approximately 20,000 and had to catch up for this in the second quarter of 2020. As a result, our Q1 2020 churn was initially reported as 38%, was actually 43% on an adjusted basis. Please consult our earnings slides posted on our Investor Relations site for membership numbers on an as-reported and as adjusted basis and accompanying commentary. This year, we're placing a high emphasis on actual cash collections for a more conservative approach to churn and membership estimates. Turning to our individual family and small business segments. First quarter revenue from this segment was $13.2 million, a 29% increase compared to a year ago. This was primarily driven by a 21% growth in approved IFP major medical plan members, combined with an increase in lifetime values of qualified health plans we sell compared to a year ago. The individual family and small business segment generated segment profit of $8.1 million compared to $2.9 million in the first quarter of 2020. Our estimated individual and family plan membership at the end of the first quarter was approximately 103,800, down 8% compared to the estimated membership we reported at the end of the first quarter a year ago. The estimated number of members on small business products was approximately 45,000, a 2% increase compared to a year ago. Our total revenue for the first quarter was $134.2 million, an increase of 26% compared to the first quarter of 2020. Our total estimated membership at the end of the quarter for all products combined was approximately 1,260,000 members. Now I would like to review our operating expenses and profitability metrics. Non-GAAP customer care enrollment costs grew 13%, well below our Medicare enrollment growth rates, reflecting increased agent productivity. Non-GAAP marketing and advertising costs grew 34%, also slower than our enrollment growth. First quarter non-GAAP tech and content and G&A expense combined grew 30% compared to a year ago. This was driven by continuing investments in our technology platform, including recent upgrades to our call center tools, a small percentage of our quarterly technology spend that was capitalized, and to a lesser extent, due to expenses related to our shareholder engagement ahead of our 2021 annual meeting. Non-GAAP operating expenses includes stock-based compensation, acquisition costs, restructuring charges and amortization of intangible assets. GAAP net loss for the first quarter of 2021 was $0.8 million compared to a net income of $3.5 million for the first quarter of 2020. In the first quarter of 2021, we booked a provision for income tax of $0.3 million compared to a tax benefit of $2 million in the first quarter a year ago. The Q1 2020 tax benefit was due to stock-based compensation adjustment that did not recur in Q1 2021. Adjusted EBITDA for the first quarter of 2021 was $17.3 million compared to $12.6 million for the first quarter of 2020. As I mentioned before, in the first quarter of 2021, we revised the calculation of adjusted EBITDA to exclude the amortization of capitalized software development costs that were $2.8 million in the first quarter of this year and $1.5 million in the first quarter a year ago. Please refer to our first quarter 2021 earnings release for a full description of how we calculate adjusted EBITDA. Our first quarter cash flow from operations was $42.8 million compared to $8.9 million for the first quarter of 2020. Trailing 12-month commission cash collections in our Medicare business were over $300 million and grew 39% compared to a year ago, driven by membership base expansion, strong new enrollment growth and higher cash collections per Medicare member. Our trailing 12-month commission cash collections per Medicare equivalent member grew 11% compared to a year ago, driven by commission rate increases on new enrollments and a larger percentage of new to Medicare Advantage enrollees and favorable carrier partner mix. As of March 31, we had $130 million in cash, cash equivalents and marketable securities and we had no debt outstanding under our line of credit. Our balance sheet also reflects a significant commissions receivable balance of approximately $742 million that is comprised of $180 million that we expect to collect over the next 12 months and $562 million in longer-term commissions receivable. We are reaffirming our 2021 annual guidance aside from increasing our adjusted EBITDA and segment profit ranges to reflect the change in methodology for calculating these financial metrics to add back amortization of capitalized software costs, which is estimated at approximately $10 million for the full year 2021 compared to $7.8 million in 2020. We now expect 2021 adjusted EBITDA to be in the range of $110 million to $125 million compared to our previous guidance of $100 million to $115 million. 2021 Medicare segment profit is now expected to be in the range of $147 million to $164 million compared to our previous guidance of $138 million to $155 million. And individual, family and small business segment profit is expected to be in the range of $19 million to $20 million compared to our previous guidance of $18 million to $19 million. I would also like to highlight that this guidance excludes the potential impact from the pending $225 million strategic investment from H.I.G. Capital announced on January 29, 2021, which is subject to certain closing conditions. Finally, I would like to discuss our outlook for the rest of the year. We expect that our year-over-year Medicare enrollment growth will slow down in Q2 compared to growth rates we just posted. As a reminder, in Q2 last year, CMS introduced a COVID-related special enrollment period for the Medicare Advantage market. This had a favorable impact on consumer demand and agent conversion rates given that more seniors were allowed to transact. In addition, in Q2, we don't expect to recognize any tail revenue to compare to approximately $2.4 million that we had booked in Q2 of 2020. Second quarter Medicare Advantage LTVs are still expected to decline in low to mid-single digits compared to a year ago. These factors combined lead to a roughly flat second quarter revenue forecast relative to Q2 of 2020. At the same time, we are starting our Medicare agent hiring early in the year. We expect this will lead to much larger sequential increase in our customer care enrollment expense from Q1 into Q2 compared to historical cadence. As a result, we currently project second quarter EBITDA loss to be in excess of $20 million. We expect to see a significant payoff in the fourth quarter, stemming from a better trained, more productive telesales force that's comprised predominantly a full-time eHealth agents. Specifically, better conversion rates are expected to result in strong enrollment growth and a significant reduction in total acquisition costs per approved Medicare member this AEP compared to a year ago. I want to remind you that these comments in our guidance are based on current indications for our business and our current estimates, assumptions and judgments, which may change at any time. Our actual results may differ as a result of changes in our estimates, assumptions and judgments. We undertake no obligations to update our comments or our guidance. Before we open the line for questions, I'd like to just remind everyone that we're here today to talk about our first quarter of fiscal year 2021 and the actions we're taking to drive growth and enhancing consumer and shareholder value. With that, we won't be commenting further on any interactions with Hudson Executive or Starboard today. We appreciate you keeping your questions focused on our performance and our results. I'll now like to open the call up for questions. Operator, please open the line.